High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas

Modern Pathology

Volumn 10, Issue 2, 1997, Pages 142-148

  Yi, Eunhee S ^a   Harclerode, Donna ^b   Gondo, Margaret ^c   Stephenson, Mark ^c   Brown, Richard W ^c   Younes, Mamoun ^c   Cagle, Philip T ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BD Technologies   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

c erbB 3; lung carcinomas; prognosis

Indexed keywords

GROWTH FACTOR RECEPTOR;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ONCOGENE C ERB; PRIORITY JOURNAL; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031046064     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Plowman GD, Culouscou J-M, Whitney GS, Green JM, Carlton GW, Foy L, et al. Ligand-specific activation of HER4/P 180 erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A 1993;90:1746-50.
2. Bacus SS, Chin C, Yarden Y, Zelnick CR, Stern DF. Type I receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors. Am J Pathol 1996;148:549-58.
3. Carraway KL, Cantley LC. A Neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 1994;78:5-8.
4. Berchuck A, Kamel A, Whitaker R, Kerns B, Olt G, Kinney R, et al. Over expression of Her2/Neu is associated with poor survival in advanced epithelial ovarian cancer. Cancer Res 1990;50:4087-91.
5. Berchuck A, Rodriguez G, Kinney RB, Soper IT, Dodge RK, Clarke-Pearson DL, et al. Overexpression of Her2/Neu in endometrial cancer is associated with advanced stage disease. Am J Obstet Gynecol 1991;164:15-21.
6. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Green MI, Torney L, et al. p 185 neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990;50: 5184-91.
7. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, et al. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 1991;51:1034-8.
8. Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, et al. Molecular cloning and expression of an additional epidermal growth factor receptor related gene. Proc Nat Acad Sci U S A 1990;87:4905-9.
9. Sandidas EE, Filipe MI, Linehan J, Lemoine NR, Gullick WJ, Rajkumar T, et al. Expression of the e-erbB-3 gene product in gastric cancer. Int J Cancer 1993;54:935-40.
10. Rajkumar T, Goden CSR, Lemoine NR, Gullick WJ. Expression of the c-erbB-3 protein in gastrointestinal tract tumors determined by monoclonal antibody RTJ1. J Pathol 1993;170: 271-8.
11. Gasparini G, Gullick WJ, Maluta S, Palma PD, Caffo O, Leonardi E, et al. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma: an immunocytochemical study. Eur J Cancer 1994;30A:16-22.
12. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C, Gullick WJ. Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 1992;7: 1273-8.
13. Hammar SP. Common neoplasms. In: Dail DH, Hammar SP, editors. Pulmonary Pathology. 2nd ed. Vol. 1. New York: Springer-Verlag, 1993:1123-32.
14. Gorgoulis VG, Barbatis C, Poulias I, Karameris AM. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erbB-2 gene product in transitional cell carcinomas of the urinary bladder: A study in Greek patients. Mod Pathol 1995;8:758-64.
15. Paik S, Hazan R, Fisher ER, Sass RE, Fisher B, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. J Clin Oncol 1990;8:103-12.
16. Jarvinen TAH, Kononen J, Pelto-Huikko M, Isola J. Expression of topoisomerase IIa is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer. Am J Pathol 1996;148:2073-82.
17. Goji J, Nakamura H, Ito H, Mabuchi O, Hashimoto K, Sano K. Expression of c-erbB2 in human neuroblastoma tissues, adrenal medulla adjacent tumor, and developing mouse neural crest cells. Am J Pathol 1995;146:660-72.
18. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 1992;89:10578-82.
19. Kitamura H, Kameda Y, Nakamura N, Inayama Y, Nakatani Y, Shibagaki T, et al. Atypical adenomatous hyperplasia and bronchoalveolar lung carcinoma. Analysis by morphometry and the expressions of p53 and carcinoembryonic antigen. Am J Surg Pathol 1996;20:553-62.
20. Cagle PT. Carcinoma of the lung. In: Thurlbeck WM, Churg AM, editors. Pathology of the Lung. 2nd ed. New York: Thieme, 1995:437-43.
21. Jiang SX, Kameya T, Sato Y, Yanase N, Yoshimura H, Kodama T. bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation. Am J Pathol 1996;148:837-46.
22. Ben-Ezra JM, Kornstein MJ, Grimes MM, Krystal G. Small cell carcinomas of the lung express the bcl-2 protein. Am J Pathol 1994;145:1036-40.